カテゴリー： QYResearch, 世界, 医療/バイオ

熱帯熱マラリア原虫診断のグローバル市場2023年：顕微鏡検査による熱帯熱マラリア原虫診断、分子診断、血清検査、熱帯熱マラリア原虫診断ため薬剤耐性検査、熱帯熱マラリア原虫診断ため抗原検出、その他

◆英語タイトル：Global Plasmodium Falciparum Diagnostics Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA4269）◆商品コード：QYR23MA4269
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：91
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界の熱帯熱マラリア原虫診断市場について調査・分析し、世界の熱帯熱マラリア原虫診断市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（顕微鏡検査による熱帯熱マラリア原虫診断、分子診断、血清検査、熱帯熱マラリア原虫診断ため薬剤耐性検査、熱帯熱マラリア原虫診断ため抗原検出、その他）、用途別セグメント分析（病院、研究所、診断センター、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Abbott Laboratories、Danaher、bioMérieux SA、Siemens AG、Bio-Rad Laboratories, Inc、Leica Microsystems、Nikon Corporation、Sysmex Partec、Olympus Corporation、ZeptoMetrix Corporation、altona Diagnostics GmbH.などが含まれています。世界の熱帯熱マラリア原虫診断市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、熱帯熱マラリア原虫診断市場規模を推定する際に考慮しました。

・熱帯熱マラリア原虫診断市場の概要
- 熱帯熱マラリア原虫診断のタイプ別セグメント
- 世界の熱帯熱マラリア原虫診断市場規模：タイプ別分析（顕微鏡検査による熱帯熱マラリア原虫診断、分子診断、血清検査、熱帯熱マラリア原虫診断ため薬剤耐性検査、熱帯熱マラリア原虫診断ため抗原検出、その他）
- 熱帯熱マラリア原虫診断の用途別セグメント
- 世界の熱帯熱マラリア原虫診断市場規模：用途別分析（病院、研究所、診断センター、クリニック、その他）
- 世界の熱帯熱マラリア原虫診断市場規模予測（2018年-2029年）

・熱帯熱マラリア原虫診断市場の成長トレンド
- 熱帯熱マラリア原虫診断の地域別市場規模（2018年-2029年）
- 熱帯熱マラリア原虫診断市場ダイナミクス
- 熱帯熱マラリア原虫診断の業界動向
- 熱帯熱マラリア原虫診断市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・タイプ別セグメント：顕微鏡検査による熱帯熱マラリア原虫診断、分子診断、血清検査、熱帯熱マラリア原虫診断ため薬剤耐性検査、熱帯熱マラリア原虫診断ため抗原検出、その他
- 世界の熱帯熱マラリア原虫診断のタイプ別市場規模（2018年-2023年）
- 世界の熱帯熱マラリア原虫診断のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、研究所、診断センター、クリニック、その他
- 世界の熱帯熱マラリア原虫診断の用途別市場規模（2018年-2023年）
- 世界の熱帯熱マラリア原虫診断の用途別市場規模（2024年-2029年）

・熱帯熱マラリア原虫診断の地域別市場規模
- 北米の熱帯熱マラリア原虫診断市場規模（2018年-2029年）
- アメリカの熱帯熱マラリア原虫診断市場規模（2018年-2029年）
- ヨーロッパの熱帯熱マラリア原虫診断市場規模（2018年-2029年）
- アジア太平洋の熱帯熱マラリア原虫診断市場規模（2018年-2029年）
- 中国の熱帯熱マラリア原虫診断市場規模（2018年-2029年）
- 日本の熱帯熱マラリア原虫診断市場規模（2018年-2029年）
- 韓国の熱帯熱マラリア原虫診断市場規模（2018年-2029年）
- インドの熱帯熱マラリア原虫診断市場規模（2018年-2029年）
- オーストラリアの熱帯熱マラリア原虫診断市場規模（2018年-2029年）
- 中南米の熱帯熱マラリア原虫診断市場規模（2018年-2029年）
- 中東・アフリカの熱帯熱マラリア原虫診断市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Abbott Laboratories、Danaher、bioMérieux SA、Siemens AG、Bio-Rad Laboratories, Inc、Leica Microsystems、Nikon Corporation、Sysmex Partec、Olympus Corporation、ZeptoMetrix Corporation、altona Diagnostics GmbH.

・アナリストの観点/結論

・調査方法とデータソース

Highlights
The global Plasmodium Falciparum Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Plasmodium Falciparum Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Plasmodium Falciparum Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Plasmodium Falciparum Diagnostics in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Plasmodium Falciparum Diagnostics include Abbott Laboratories, Danaher, bioMérieux SA, Siemens AG, Bio-Rad Laboratories, Inc, Leica Microsystems, Nikon Corporation, Sysmex Partec and Olympus Corporation, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasmodium Falciparum Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmodium Falciparum Diagnostics.
The Plasmodium Falciparum Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Plasmodium Falciparum Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmodium Falciparum Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
Danaher
bioMérieux SA
Siemens AG
Bio-Rad Laboratories, Inc
Leica Microsystems
Nikon Corporation
Sysmex Partec
Olympus Corporation
ZeptoMetrix Corporation
altona Diagnostics GmbH.
Segment by Type
Microscopy Tests for Plasmodium Falciparum Diagnostics
Molecular Diagnosis
Serology for Plasmodium Falciparum Diagnostics
Drug Resistance Tests for Plasmodium Falciparum Diagnostics
Antigen Detection for Plasmodium Falciparum Diagnostics
Others
Segment by Application
Hospitals
Research Centers
Diagnostic Centers
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmodium Falciparum Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmodium Falciparum Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Microscopy Tests for Plasmodium Falciparum Diagnostics
1.2.3 Molecular Diagnosis
1.2.4 Serology for Plasmodium Falciparum Diagnostics
1.2.5 Drug Resistance Tests for Plasmodium Falciparum Diagnostics
1.2.6 Antigen Detection for Plasmodium Falciparum Diagnostics
1.2.7 Others
1.3 Market by Application
1.3.1 Global Plasmodium Falciparum Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Research Centers
1.3.4 Diagnostic Centers
1.3.5 Clinics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmodium Falciparum Diagnostics Market Perspective (2018-2029)
2.2 Plasmodium Falciparum Diagnostics Growth Trends by Region
2.2.1 Global Plasmodium Falciparum Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Plasmodium Falciparum Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Plasmodium Falciparum Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Plasmodium Falciparum Diagnostics Market Dynamics
2.3.1 Plasmodium Falciparum Diagnostics Industry Trends
2.3.2 Plasmodium Falciparum Diagnostics Market Drivers
2.3.3 Plasmodium Falciparum Diagnostics Market Challenges
2.3.4 Plasmodium Falciparum Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmodium Falciparum Diagnostics Players by Revenue
3.1.1 Global Top Plasmodium Falciparum Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Plasmodium Falciparum Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Plasmodium Falciparum Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmodium Falciparum Diagnostics Revenue
3.4 Global Plasmodium Falciparum Diagnostics Market Concentration Ratio
3.4.1 Global Plasmodium Falciparum Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmodium Falciparum Diagnostics Revenue in 2022
3.5 Plasmodium Falciparum Diagnostics Key Players Head office and Area Served
3.6 Key Players Plasmodium Falciparum Diagnostics Product Solution and Service
3.7 Date of Enter into Plasmodium Falciparum Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmodium Falciparum Diagnostics Breakdown Data by Type
4.1 Global Plasmodium Falciparum Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Plasmodium Falciparum Diagnostics Forecasted Market Size by Type (2024-2029)
5 Plasmodium Falciparum Diagnostics Breakdown Data by Application
5.1 Global Plasmodium Falciparum Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Plasmodium Falciparum Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Plasmodium Falciparum Diagnostics Market Size (2018-2029)
6.2 North America Plasmodium Falciparum Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Plasmodium Falciparum Diagnostics Market Size by Country (2018-2023)
6.4 North America Plasmodium Falciparum Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmodium Falciparum Diagnostics Market Size (2018-2029)
7.2 Europe Plasmodium Falciparum Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Plasmodium Falciparum Diagnostics Market Size by Country (2018-2023)
7.4 Europe Plasmodium Falciparum Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Plasmodium Falciparum Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Plasmodium Falciparum Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmodium Falciparum Diagnostics Market Size (2018-2029)
9.2 Latin America Plasmodium Falciparum Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Plasmodium Falciparum Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Plasmodium Falciparum Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Plasmodium Falciparum Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Plasmodium Falciparum Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Plasmodium Falciparum Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Plasmodium Falciparum Diagnostics Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Plasmodium Falciparum Diagnostics Introduction
11.2.4 Danaher Revenue in Plasmodium Falciparum Diagnostics Business (2018-2023)
11.2.5 Danaher Recent Development
11.3 bioMérieux SA
11.3.1 bioMérieux SA Company Detail
11.3.2 bioMérieux SA Business Overview
11.3.3 bioMérieux SA Plasmodium Falciparum Diagnostics Introduction
11.3.4 bioMérieux SA Revenue in Plasmodium Falciparum Diagnostics Business (2018-2023)
11.3.5 bioMérieux SA Recent Development
11.4 Siemens AG
11.4.1 Siemens AG Company Detail
11.4.2 Siemens AG Business Overview
11.4.3 Siemens AG Plasmodium Falciparum Diagnostics Introduction
11.4.4 Siemens AG Revenue in Plasmodium Falciparum Diagnostics Business (2018-2023)
11.4.5 Siemens AG Recent Development
11.5 Bio-Rad Laboratories, Inc
11.5.1 Bio-Rad Laboratories, Inc Company Detail
11.5.2 Bio-Rad Laboratories, Inc Business Overview
11.5.3 Bio-Rad Laboratories, Inc Plasmodium Falciparum Diagnostics Introduction
11.5.4 Bio-Rad Laboratories, Inc Revenue in Plasmodium Falciparum Diagnostics Business (2018-2023)
11.5.5 Bio-Rad Laboratories, Inc Recent Development
11.6 Leica Microsystems
11.6.1 Leica Microsystems Company Detail
11.6.2 Leica Microsystems Business Overview
11.6.3 Leica Microsystems Plasmodium Falciparum Diagnostics Introduction
11.6.4 Leica Microsystems Revenue in Plasmodium Falciparum Diagnostics Business (2018-2023)
11.6.5 Leica Microsystems Recent Development
11.7 Nikon Corporation
11.7.1 Nikon Corporation Company Detail
11.7.2 Nikon Corporation Business Overview
11.7.3 Nikon Corporation Plasmodium Falciparum Diagnostics Introduction
11.7.4 Nikon Corporation Revenue in Plasmodium Falciparum Diagnostics Business (2018-2023)
11.7.5 Nikon Corporation Recent Development
11.8 Sysmex Partec
11.8.1 Sysmex Partec Company Detail
11.8.2 Sysmex Partec Business Overview
11.8.3 Sysmex Partec Plasmodium Falciparum Diagnostics Introduction
11.8.4 Sysmex Partec Revenue in Plasmodium Falciparum Diagnostics Business (2018-2023)
11.8.5 Sysmex Partec Recent Development
11.9 Olympus Corporation
11.9.1 Olympus Corporation Company Detail
11.9.2 Olympus Corporation Business Overview
11.9.3 Olympus Corporation Plasmodium Falciparum Diagnostics Introduction
11.9.4 Olympus Corporation Revenue in Plasmodium Falciparum Diagnostics Business (2018-2023)
11.9.5 Olympus Corporation Recent Development
11.10 ZeptoMetrix Corporation
11.10.1 ZeptoMetrix Corporation Company Detail
11.10.2 ZeptoMetrix Corporation Business Overview
11.10.3 ZeptoMetrix Corporation Plasmodium Falciparum Diagnostics Introduction
11.10.4 ZeptoMetrix Corporation Revenue in Plasmodium Falciparum Diagnostics Business (2018-2023)
11.10.5 ZeptoMetrix Corporation Recent Development
11.11 altona Diagnostics GmbH.
11.11.1 altona Diagnostics GmbH. Company Detail
11.11.2 altona Diagnostics GmbH. Business Overview
11.11.3 altona Diagnostics GmbH. Plasmodium Falciparum Diagnostics Introduction
11.11.4 altona Diagnostics GmbH. Revenue in Plasmodium Falciparum Diagnostics Business (2018-2023)
11.11.5 altona Diagnostics GmbH. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 熱帯熱マラリア原虫診断のグローバル市場2023年：顕微鏡検査による熱帯熱マラリア原虫診断、分子診断、血清検査、熱帯熱マラリア原虫診断ため薬剤耐性検査、熱帯熱マラリア原虫診断ため抗原検出、その他(Global Plasmodium Falciparum Diagnostics Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ポイントオブケア（POC）/迅速診断のグローバル市場2023年：迅速検査、分子診断
  • 世界のマラリア診断市場2023-2030：顕微鏡、迅速診断検査（RDT）、分子診断
  • ポイントオブケア（POC）がんスクリーニングのグローバル市場2023年：遺伝子検査、画像検査、その他
  • アレルギー診断のグローバル市場2023年：消耗品、器具、サービス

    • ◆H&Iグローバルリサーチのお客様（例）◆